PJSC RN-Western Siberia carries a market capitalization of 2.31B, placing it among publicly traded companies globally. Its enterprise value stands at 1.54B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.31B |
| Enterprise Value | 1.54B |
PJSC RN-Western Siberia currently has 26.77M shares outstanding.
| Shares Outstanding | 26.77M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
PJSC RN-Western Siberia trades at a trailing price-to-earnings ratio of 38.86. The price-to-sales ratio is 24.25, and the price-to-book ratio stands at 0.55.
| PE Ratio | 38.86 |
| PS Ratio | 24.25 |
| PB Ratio | 0.55 |
| P/TBV Ratio | 0.55 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
| EV / Sales | 24.25 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
PJSC RN-Western Siberia maintains a current ratio of 45.91, meaning it holds 45.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 45.91 |
| Quick Ratio | 0.02 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
PJSC RN-Western Siberia posts a return on equity of 1.42 and a return on invested capital of -1.44.
| Return on Equity (ROE) | 1.42 |
| Return on Assets (ROA) | 1.40 |
| Return on Invested Capital (ROIC) | -1.44 |
| Return on Capital Employed (ROCE) | 1.42 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 268.49 |
Over the trailing twelve months, PJSC RN-Western Siberia has paid 10.41M in income taxes, reflecting an effective tax rate of 20.77.
| Income Tax | 10.41M |
| Effective Tax Rate | 20.77 |
PJSC RN-Western Siberia's stock has gained approximately 9.94898% over the past 52 weeks. The 50-day moving average sits at 38.40, while the 200-day moving average is 38.40.
| Beta (5Y) | N/A |
| 52-Week Price Change | 9.94898% |
| 50-Day Moving Average | 38.40 |
| 200-Day Moving Average | 38.40 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, PJSC RN-Western Siberia generated 63.58M in revenue and converted that into 39.68M in net income, yielding earnings per share of 1.48. EBITDA reached -51.04M, while operating income came in at -51.04M.
| Revenue | 63.58M |
| Gross Profit | 4.38M |
| Operating Income | -51.04M |
| Pretax Income | 50.09M |
| Net Income | 39.68M |
| EBITDA | -51.04M |
| EBIT | -51.04M |
| Earnings Per Share (EPS) | 1.48 |
Total book value stands at 2.82B, with working capital of 1.05B providing operational flexibility.
| Cash & Cash Equivalents | 546,000.00 |
| Total Debt | N/A |
| Net Debt | -546,000.00 |
| Equity (Book Value) | 2.82B |
| Book Value Per Share | 105.31 |
| Working Capital | 1.05B |
PJSC RN-Western Siberia operates with a gross margin of 6.88, reflecting its pricing power and cost economics. The operating margin of -80.27 and net profit margin of 62.42 provide insight into operational efficiency.
| Gross Margin | 6.88 |
| Operating Margin | -80.27 |
| Pretax Margin | 78.78 |
| Profit Margin | 62.42 |
| EBITDA Margin | -80.27 |
PJSC RN-Western Siberia posts an Altman Z-Score of 41.26, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 41.26 |